MAURI ROGERS: Open Payments
NPI 1780160085 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 18 payments from 7 companies in 2025. Trend: 2023 $379 · 2024 $402 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $179 |
| Seqirus USA Inc | 2 | $55 |
| ABBVIE INC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lundbeck LLC | 1 | $32 |
| PFIZER INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Ozempic, REXULTI, Fluad, VRAYLAR, Wegovy, QULIPTA, PAXLOVID, Rybelsus.
Industry payments across AR — which companies pay providers there.
